Elevance Health, Inc. (ELV) operating KPIs
ELVNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Oct 21, 2026Score 15/3012% below fair value
$420.07−1.95 (-0.46%)
Close on Oct 30, 2026Market cap $91.10BP/E 18.7Yield –
Elevance Health total Reportable Segments — GAAP Operating Gain ($M)
Quarterly figures from Elevance Health's filings and investor materials
Latest, Q3 2026
1,269
Period ended Sep 30, 2026
Change on a year earlier
-2.0%
1,295 in Q3 2025
History
25 quarters
Since Q2 2020
Sources
19
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Total Reportable Segments — GAAP Operating Gain ($M) | Year on year | Source |
|---|---|---|---|---|
| Q3 2026 | Sep 30, 2026 | 1,269 | -2.0% | 8-K ER (FY2026Q3, 2026-10-21) ↗ |
| Q2 2026 | Jun 30, 2026 | 1,763 | -27.3% | 8-K ER (FY2026Q2, 2026-07-15) ↗ |
| Q1 2026 | Mar 31, 2026 | 2,086 | -34.2% | 8-K ER (FY2026Q1, 2026-04-22) ↗ |
| Q4 2025 | Dec 31, 2025 | 309 | -54.1% | 8-K ER (FY2025Q4, 2026-01-28) ↗ |
| Q3 2025 | Sep 30, 2025 | 1,295 | -8.0% | 8-K ER (FY2026Q3, 2026-10-21) ↗ |
| Q2 2025 | Jun 30, 2025 | 2,425 | -12.3% | 8-K ER (FY2026Q2, 2026-07-15) ↗ |
| Q1 2025 | Mar 31, 2025 | 3,170 | +5.1% | 8-K ER (FY2026Q1, 2026-04-22) ↗ |
| Q4 2024 | Dec 31, 2024 | 673 | -47.6% | 8-K ER (FY2025Q4, 2026-01-28) ↗ |
| Q3 2024 | Sep 30, 2024 | 1,408 | -19.8% | 8-K ER (FY2025Q3, 2025-10-21) ↗ |
| Q2 2024 | Jun 30, 2024 | 2,765 | +5.2% | 8-K ER (FY2025Q2, 2025-07-17) ↗ |
| Q1 2024 | Mar 31, 2024 | 3,016 | +6.5% | 8-K ER (FY2025Q1, 2025-04-22) ↗ |
| Q4 2023 | Dec 31, 2023 | 1,284 | +2.0% | 8-K ER (FY2024Q4, 2025-01-23) ↗ |
| Q3 2023 | Sep 30, 2023 | 1,756 | -22.0% | 8-K ER (FY2024Q3, 2024-10-17) ↗ |
| Q2 2023 | Jun 30, 2023 | 2,628 | +12.0% | 8-K ER (FY2024Q2, 2024-07-17) ↗ |
| Q1 2023 | Mar 31, 2023 | 2,831 | +16.6% | 8-K ER (FY2024Q1, 2024-04-18) ↗ |
| Q4 2022 | Dec 31, 2022 | 1,259 | -46.8% | 8-K ER (FY2023Q4, 2024-01-24) ↗ |
| Q3 2022 | Sep 30, 2022 | 2,251 | +9.3% | 8-K ER (FY2023Q3, 2023-10-18) ↗ |
| Q2 2022 | Jun 30, 2022 | 2,346 | +12.7% | 8-K ER (FY2023Q2, 2023-07-19) ↗ |
| Q1 2022 | Mar 31, 2022 | 2,427 | – | 8-K ER (FY2023Q1, 2023-04-19) ↗ |
| Q4 2021 | Dec 31, 2021 | 2,367 | +291.2% | 8-K ER (FY2022Q4, 2023-01-25) ↗ |
| Q3 2021 | Sep 30, 2021 | 2,059 | +924.4% | 8-K ER (FY2021Q3, 2021-10-20) ↗ |
| Q2 2021 | Jun 30, 2021 | 2,081 | -38.1% | 8-K ER (FY2021Q2, 2021-07-21) ↗ |
| Q4 2020 | Dec 31, 2020 | 605 | – | 8-K ER (FY2021Q4, 2022-01-26) ↗ |
| Q3 2020 | Sep 30, 2020 | 201 | – | 8-K ER (FY2021Q3, 2021-10-20) ↗ |
| Q2 2020 | Jun 30, 2020 | 3,360 | – | 8-K ER (FY2021Q2, 2021-07-21) ↗ |
Breakdown
What makes up total reportable segments — gaap operating gain
- Total Reportable Segments — Adjusted Operating Gain (Non-GAAP)1,337 · Q3 2026
- Non-GAAP Adjustment Items to Reportable Segments Operating Gain68 · Q3 2026
- Health Benefits Segment — GAAP Operating Gain (Loss)436 · Q3 2026
- Total Carelon — GAAP Operating Gain908 · Q3 2026
- Corporate & Other — Unallocated Operating Loss-75 · Q3 2026
Cite this data
StockData. (2026). Elevance Health Total Reportable Segments — GAAP Operating Gain ($M), quarterly Q2 2020–Q3 2026 [Data set]. Compiled from Elevance Health SEC filings and investor materials. https://stockdatahq.com/stocks/elv/kpis/seg_op_gain_consolidated_total
See every metric in the Elevance Health KPI table. Data updated Oct 28, 2026.